This company has been marked as potentially delisted and may not be actively trading. XORTX Therapeutics (XRTX) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsEarningsHeadlinesShort InterestTrendsBuy This Stock XRTX vs. COSM, PHIO, LYRA, NERV, ADXN, TLPH, BMRA, KPRX, TCRT, and NLSPShould you be buying XORTX Therapeutics stock or one of its competitors? The main competitors of XORTX Therapeutics include Cosmos Health (COSM), Phio Pharmaceuticals (PHIO), Lyra Therapeutics (LYRA), Minerva Neurosciences (NERV), Addex Therapeutics (ADXN), Talphera (TLPH), Biomerica (BMRA), Kiora Pharmaceuticals (KPRX), Alaunos Therapeutics (TCRT), and NLS Pharmaceutics (NLSP). These companies are all part of the "med - drugs" industry. XORTX Therapeutics vs. Its Competitors Cosmos Health Phio Pharmaceuticals Lyra Therapeutics Minerva Neurosciences Addex Therapeutics Talphera Biomerica Kiora Pharmaceuticals Alaunos Therapeutics NLS Pharmaceutics XORTX Therapeutics (NASDAQ:XRTX) and Cosmos Health (NASDAQ:COSM) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, earnings, valuation, media sentiment, profitability, analyst recommendations and risk. Does the media refer more to XRTX or COSM? In the previous week, Cosmos Health had 1 more articles in the media than XORTX Therapeutics. MarketBeat recorded 2 mentions for Cosmos Health and 1 mentions for XORTX Therapeutics. Cosmos Health's average media sentiment score of 0.63 beat XORTX Therapeutics' score of 0.00 indicating that Cosmos Health is being referred to more favorably in the news media. Company Overall Sentiment XORTX Therapeutics Neutral Cosmos Health Positive Which has higher valuation & earnings, XRTX or COSM? XORTX Therapeutics has higher earnings, but lower revenue than Cosmos Health. XORTX Therapeutics is trading at a lower price-to-earnings ratio than Cosmos Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioXORTX TherapeuticsN/AN/A-$3.31M-$1.35-0.71Cosmos Health$54.43M0.25-$16.18M-$1.08-0.44 Is XRTX or COSM more profitable? XORTX Therapeutics has a net margin of 0.00% compared to Cosmos Health's net margin of -28.26%. Cosmos Health's return on equity of -17.25% beat XORTX Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets XORTX TherapeuticsN/A -36.38% -24.45% Cosmos Health -28.26%-17.25%-8.57% Which has more risk and volatility, XRTX or COSM? XORTX Therapeutics has a beta of 0.51, meaning that its stock price is 49% less volatile than the S&P 500. Comparatively, Cosmos Health has a beta of 5.2, meaning that its stock price is 420% more volatile than the S&P 500. Do institutionals & insiders believe in XRTX or COSM? 0.2% of XORTX Therapeutics shares are held by institutional investors. Comparatively, 12.6% of Cosmos Health shares are held by institutional investors. 6.9% of XORTX Therapeutics shares are held by insiders. Comparatively, 15.6% of Cosmos Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. SummaryCosmos Health beats XORTX Therapeutics on 10 of the 12 factors compared between the two stocks. Get XORTX Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for XRTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding XRTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart XRTX vs. The Competition Export to ExcelMetricXORTX TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.63M$2.50B$5.60B$9.10BDividend YieldN/A1.79%5.24%4.00%P/E Ratio-3.309.4227.9620.25Price / SalesN/A723.99429.2099.14Price / CashN/A165.3637.4658.16Price / Book1.094.608.045.49Net Income-$3.31M$31.26M$3.18B$250.27M XORTX Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)XRTXXORTX Therapeutics0.0472 of 5 stars$0.96+10.1%N/A-46.0%$3.63MN/A-3.30N/AGap UpCOSMCosmos Health2.4274 of 5 stars$0.46+3.3%N/A-63.0%$12.81M$54.43M-0.43100News CoveragePHIOPhio Pharmaceuticals2.5708 of 5 stars$2.50-2.0%$14.00+460.0%-60.5%$12.23MN/A-0.3910LYRALyra Therapeutics2.3944 of 5 stars$9.25+2.4%$100.00+981.1%-40.8%$11.97M$1.53M-0.1550NERVMinerva Neurosciences4.2406 of 5 stars$1.63-0.6%$5.00+206.7%-48.4%$11.47MN/A1.999News CoverageADXNAddex Therapeutics2.5277 of 5 stars$9.52+1.5%$30.00+215.1%+5.8%$10.05M$460K-28.0030Gap DownTLPHTalphera2.0115 of 5 stars$0.49+5.2%$5.00+926.1%-42.3%$9.49M$650K-1.0819Positive NewsBMRABiomerica1.135 of 5 stars$3.27-3.8%N/A+7.3%$8.66M$5.41M-1.4160KPRXKiora Pharmaceuticals3.2313 of 5 stars$2.86+1.8%$10.00+249.7%-29.1%$8.55M$16.02M-0.9910TCRTAlaunos Therapeutics0.4719 of 5 stars$5.07-0.8%N/A-24.4%$8.38M$10K-2.0040NLSPNLS PharmaceuticsN/A$2.32+2.2%N/A+924.4%$8.17MN/A0.006 Related Companies and Tools Related Companies COSM Alternatives PHIO Alternatives LYRA Alternatives NERV Alternatives ADXN Alternatives TLPH Alternatives BMRA Alternatives KPRX Alternatives TCRT Alternatives NLSP Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:XRTX) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding XORTX Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share XORTX Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free XRTX Stock Alerts